Barclays’s Herbalife HLF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,200
| Closed | -$202K | – | 4911 |
|
|
2020
Q4 | $202K | Hold |
4,200
| – | – | ﹤0.01% | 3758 |
|
|
2020
Q3 | $196K | Sell |
4,200
-3,000
| -42% | -$147K | ﹤0.01% | 3867 |
|
|
2020
Q2 | $324K | Sell |
7,200
-13,100
| -65% | -$509K | ﹤0.01% | 3679 |
|
|
2020
Q1 | $592K | Buy |
20,300
+11,200
| +123% | +$417K | ﹤0.01% | 3449 |
|
|
2019
Q4 | $434K | Buy |
9,100
+1,500
| +20% | +$65K | ﹤0.01% | 4412 |
|
|
2019
Q3 | $288K | Sell |
7,600
-68,800
| -90% | -$2.69M | ﹤0.01% | 4692 |
|
|
2019
Q2 | $3.27M | Buy |
76,400
+65,700
| +614% | +$3.11M | ﹤0.01% | 2329 |
|
|
2019
Q1 | $567K | Buy |
10,700
+4,700
| +78% | +$270K | ﹤0.01% | 3995 |
|
|
2018
Q4 | $354K | Sell |
6,000
-1,300
| -18% | -$71.8K | ﹤0.01% | 4138 |
|
|
2018
Q3 | $398K | Buy |
7,300
+1,900
| +35% | +$105K | ﹤0.01% | 4460 |
|
|
2018
Q2 | $290K | Sell |
5,400
-15,600
| -74% | -$820K | ﹤0.01% | 4414 |
|
|
2018
Q1 | $1.02M | Sell |
21,000
-122,400
| -85% | -$5.2M | ﹤0.01% | 3186 |
|
|
2017
Q4 | $4.86M | Sell |
143,400
-119,800
| -46% | -$4.2M | ﹤0.01% | 1676 |
|
|
2017
Q3 | $8.93M | Sell |
263,200
-48,600
| -16% | -$1.66M | 0.01% | 1123 |
|
|
2017
Q2 | $11.1M | Buy |
311,800
+250,600
| +409% | +$8.45M | 0.01% | 904 |
|
|
2017
Q1 | $1.78M | Sell |
61,200
-401,200
| -87% | -$11.2M | ﹤0.01% | 2205 |
|
|
2016
Q4 | $11.1M | Buy |
462,400
+119,600
| +35% | +$3.27M | 0.01% | 885 |
|
|
2016
Q3 | $10.6M | Buy |
342,800
+194,600
| +131% | +$6.15M | 0.01% | 845 |
|
|
2016
Q2 | $4.34M | Sell |
148,200
-114,400
| -44% | -$3.42M | 0.01% | 1422 |
|
|
2016
Q1 | $8.01M | Sell |
262,600
-229,400
| -47% | -$5.92M | 0.01% | 883 |
|
|
2015
Q4 | $13M | Buy |
492,000
+182,600
| +59% | +$5.07M | 0.02% | 761 |
|
|
2015
Q3 | $8.35M | Sell |
309,400
-55,600
| -15% | -$1.52M | 0.01% | 1043 |
|
|
2015
Q2 | $10M | Sell |
365,000
-497,800
| -58% | -$12.1M | 0.01% | 1029 |
|
|
2015
Q1 | $18.1M | Sell |
862,800
-70,400
| -8% | -$1.2M | 0.02% | 732 |
|
|
2014
Q4 | $17.3M | Buy |
933,200
+127,200
| +16% | +$2.72M | 0.02% | 839 |
|
|
2014
Q3 | $17.3M | Buy |
806,000
+174,600
| +28% | +$4.67M | 0.02% | 808 |
|
|
2014
Q2 | $20.2M | Sell |
631,400
-6,600
| -1% | -$202K | 0.02% | 691 |
|
|
2014
Q1 | $18.2M | Sell |
638,000
-708,400
| -53% | -$23.4M | 0.02% | 752 |
|
|
2013
Q4 | $52.5M | Sell |
1,346,400
-226,600
| -14% | -$7.85M | 0.05% | 322 |
|
|
2013
Q3 | $54.3M | Buy |
1,573,000
+762,800
| +94% | +$23.6M | 0.06% | 269 |
|
|
2013
Q2 | $18.3M | Buy |
+810,200
| New | +$17.2M | 0.02% | 686 |
|
Other funds holding HLF
BG
ROIC
VPM
VCM
Barclays's HLF Position: Q1 2026 in Review
Barclays reduced its Herbalife (HLF) stake by 88% in Q1 2026, selling an estimated $2.28M and leaving 19,732 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #3486.
Barclays first reported a position in HLF in Q2 2013 and has held it in 51 quarters since. The position peaked at $25M in Q4 2013. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.
- Barclays held 19,732 shares of Herbalife worth $290K as of Q1 2026.
- Barclays sold 139,868 Herbalife shares in Q1 2026, an estimated $2.28M.
- Herbalife made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3486 holding.
- Barclays first reported a position in Herbalife in Q2 2013 and has held it in 51 quarters since.
- Barclays's Herbalife position peaked at $25M in Q4 2013.
- 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.